Rose E. Sekulovich

Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection

Lawrence Corey, Andria Langenberg, Rhoda L. Ashley et al. · JAMA · 1999 · 483 citations

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

Robert F. Pass, Anne‐Marie Duliège, Suresh B. Boppana et al. · The Journal of Infectious Diseases · 1999 · 247 citations

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

Stephen E. Straus, Barbara Savarese, Philip R. Krause et al. · The Lancet · 1994 · 206 citations

Vaccination, Vaccine Development, Vaccine Target +9

The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0

Rose E. Sekulovich, K Leary, R M Sandri-Goldin · Journal of Virology · 1988 · 188 citations · Full text

Viral Replication, Viral Pathogenesis, Immunology +16

Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial

Stephen E. Straus, Anna Wald, Rhonda G. Kost et al. · The Journal of Infectious Diseases · 1997 · 168 citations · Full text